Skip to content

Periventricular white matter lesions in small vessel disease related cognitive decline

Periventricular white matter lesions in small vessel disease related cognitive decline - Small vessel disease and cognitive function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39446
Enrollment
150
Registered
2009-07-15
Start date
2009-08-04
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lacunar infarct silent lesions

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - First lacunar infarct, diagnosed clinically as well as radiologically. - Age of 18 years and older.

Exclusion criteria

Exclusion criteria: - Brain infarct or other cerebral pathology in recent history. - Potential source of cardio-embolism or carotic stenosis (large vessel disease) - Severe comorbidity (specified as not being able to perform Activities of Daily Living (ADL independently)), including dementia. - Limited life-expectancy - History of inflammatory disease - Contra indications for MRI o Heart valve prosthesis o Pacemaker o Intracerebral clips (aneurysm) o Intra-ocular metal pieces o Cochlear implant o Claustrophobia - When the patient does not appreciate to receive the results of the study, in particular if abnormalities are found during MRI or neuropsychological assessment, which are of great importance for the patients health.

Design outcomes

Primary

MeasureTime frame
Cognitive function based on several (neuro)psychological domains: information processing speed, attention/concentration, executive functioning, memory and language. Raw test scores will be used for analyses. Presence/ progression WMLs.

Secondary

MeasureTime frame
Brain Microbleeds. Other cerebral abnormalities observed by MRI: atrophy and other cerebral abnormalities.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)